1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 75, 2024
  5. Article

Annual Review of Medicine

Volume 75, 2024

Effects on Cancer Prevention from the COVID-19 Pandemic

Abstract

The COVID-19 pandemic led to disruption of health services around the world, including cancer services. We carried out a narrative review of the effect of the pandemic on cancer prevention services, including screening. Services were severely affected in the early months of the pandemic, and in some areas are still recovering. Large numbers of additional cancers or additional late-stage cancers have been predicted to arise over the coming years as a result of this disruption. To minimize the effects on cancer outcomes, it is necessary to return as quickly as possible to prepandemic levels of screening and prevention activity or indeed to exceed these levels. The recovery of services should address health inequalities.

Keyword(s): cancer prevention, cancer screening, COVID-19, pandemic
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-051022-122257
2024-01-29
2024-05-06
Loading full text...

Full text loading...

/deliver/fulltext/med/75/1/annurev-med-051022-122257.html?itemId=/content/journals/10.1146/annurev-med-051022-122257&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Rosen R, Wieringa S, Greenhalgh T et al. 2022. Clinical risk in remote consultations in general practice: findings from in-COVID-19 pandemic qualitative research. BJGP Open 6:BJGPO.2021.0204
     [Google Scholar]
  2. 2.
    Murphy M, Scott LJ, Salisbury C et al. 2021. Implementation of remote consulting in UK primary care following the COVID-19 pandemic: a mixed methods longitudinal study. Br. J. Gen. Pract. 71:704e166–77
     [Google Scholar]
  3. 3.
    Duffy SW, Seedat F, Kearins O et al. 2022. The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. Br. J. Cancer 126L:1355–61
     [Google Scholar]
  4. 4.
    Figueroa JD, Gray E, Pashayan N et al. 2021. The impact of the COVID-19 pandemic on breast cancer early detection and screening. Prev. Med. 151:106585
     [Google Scholar]
  5. 5.
    Barsouk A, Saginala K, Aluru JS et al. 2022. US cancer screening recommendations: developments and the impact of COVID-19. Med. Sci. 10:116
     [Google Scholar]
  6. 6.
    Pediconi F, Galati F, Bernardi D et al. 2020. Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM. Radiol. Med. 125:926–30
     [Google Scholar]
  7. 7.
    Chirayath S, Bahirwani J, Kaur P et al. 2021. Effect of using personal protective equipment during the COVID-19 pandemic on the quality indicators of screening colonoscopies. Gastroenterol. Res. Pract. 2021:8910004
     [Google Scholar]
  8. 8.
    Wang L. 2022. Working to close the cancer screening gap caused by COVID. Cancer Currents Blog May 17. https://www.cancer.gov/news-events/cancer-currents-blog/2022/covid-increasing-cancer-screening. Accessed Mar. 17, 2023
    [Google Scholar]
  9. 9.
    Soerjomataram I, Bray F, Lansdorp-Vogelaar I et al. 2022. COVID-19 and Cancer Global Modelling Consortium (CCGMC): a global reference to inform national recovery strategies. J. Cancer Policy 32:100328
     [Google Scholar]
  10. 10.
    COVIDSurg Collab 2021. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol 22:111507–17
     [Google Scholar]
  11. 11.
    Walker MJ, Wang J, Mazuryk J et al. 2022. Delivery of cancer care in Ontario, Canada, during the first year of the COVID-19 pandemic. JAMA Netw. Open 5:4e228855
     [Google Scholar]
  12. 12.
    Gheorghe A, Maringe C, Spice J et al. 2021. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: a national population-based modelling study in England, UK. Eur. J. Cancer 152:233–42
     [Google Scholar]
  13. 13.
    Bakaloudi DR, Evripidou K, Siargkas A et al. 2023. Impact of COVID-19 lockdown on smoking and vaping: systematic review and meta-analysis. Public Health 218:160–72
     [Google Scholar]
  14. 14.
    Asare S, Xue Z, Majmundar A et al. 2022. Changes in state-level cigarette sales during the COVID-19 pandemic. JAMA Netw. Open 5:12e2248678
     [Google Scholar]
  15. 15.
    Kim J, Lee S. 2022. Impact of the COVID-19 pandemic on tobacco sales and national smoking cessation services in Korea. Int. J. Environ. Res. Public Health 19:95000
     [Google Scholar]
  16. 16.
    Statista 2023. Annual expenditure on tobacco in the United Kingdom from 2005 to 2022, based on volume. Statista https://www.statista.com/statistics/300836/annual-expenditure-on-tobacco-in-the-united-kingdom-uk/. Accessed May 30, 2023
    [Google Scholar]
  17. 17.
    Fosgaard TR, Pizzo A, Sadoff S. 2022. Sustained decline in tobacco purchasing in Denmark during the COVID-19 pandemic. Commun. Med. 2:96
     [Google Scholar]
  18. 18.
    Alqahtani JS, Alghamdi SM, Aldhahir AM et al. 2021. Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19. Front. Biosci. 26:7246–52
     [Google Scholar]
  19. 19.
    Meacham MC, Vogel EA, Thrul J et al. 2021. Addressing cigarette smoking cessation treatment challenges during the COVID-19 pandemic with social media. J. Subst. Abuse Treat. 129:108379
     [Google Scholar]
  20. 20.
    Sohi I, Chrystoja BR, Rehm J et al. 2022. Changes in alcohol use during the COVID-19 pandemic and previous pandemics: a systematic review. Alcohol Clin. Exp. Res. 46:4498–513
     [Google Scholar]
  21. 21.
    Plata A, Motoki K, Spence C et al. 2022. Trends in alcohol consumption in relation to the COVID-19 pandemic: a cross-country analysis. Int. J. Gastron. Food Sci. 27:100397
     [Google Scholar]
  22. 22.
    Sideli L, Lo Coco G, Bonfanti RC et al. 2021. Effects of COVID-19 lockdown on eating disorders and obesity: a systematic review and meta-analysis. Eur. Eat. Disord. Rev. 29:6826–41
     [Google Scholar]
  23. 23.
    Khubchandani J, Price JH, Sharma S et al. 2022. COVID-19 pandemic and weight gain in American adults: a nationwide population-based study. Diabetes Metab. Syndr. 16:1102392
     [Google Scholar]
  24. 24.
    Bell M, Duncan MJ, Patte KA et al. 2023. Changes in body mass, physical activity, and dietary intake during the COVID-19 pandemic lockdowns in Canadian university students. Biology 12:2326
     [Google Scholar]
  25. 25.
    Rababah T, Al-U'datt M, Angor MM et al. 2023. Impact of COVID-19 pandemic on obesity among adults in Jordan. Front. Nutr. 10:1114076
     [Google Scholar]
  26. 26.
    Kwiatkowska I, Olszak J, Formanowicz P et al. 2023. Dietary habits and lifestyle, including cardiovascular risk among vegetarians and omnivores during the COVID-19 pandemic in the Polish population. Nutrients 15:2442
     [Google Scholar]
  27. 27.
    Taniguchi H, Okuda N, Arima H et al. 2022. Body weight and lifestyle changes under the COVID-19 pandemic in Japan: a cross-sectional study from NIPPON DATA2010. BMJ Open 12:11e063213
     [Google Scholar]
  28. 28.
    Franklin J, Sim KA, Swinbourne JM et al. 2023. Obesity, lifestyle behaviours and psychological effects of the COVID-19 lockdown: a survey of patients attending a tertiary weight loss clinic. Clin. Obes. 13:2e12567
     [Google Scholar]
  29. 29.
    Chido-Amajuoyi OG, Pande M, Agbajogu C et al. 2022. HPV vaccination uptake, hesitancy, and refusal: observations of health-care professionals during the COVID-19 pandemic. JNCI Cancer Spectr. 6:4pkac053
     [Google Scholar]
  30. 30.
    Natl. Inst. Health Care Excel 2022. Vaccine uptake in the general population: evidence review for the barriers to, and facilitators for, vaccine uptake NICE Guideline NG218 Natl. Inst. Health Care Excel. London: https://www.nice.org.uk/guidance/ng218/evidence/b-barriers-to-and-facilitators-for-vaccine-uptake-pdf-11072221743. Accessed July 11, 2023
  31. 31.
    Ferrara P, Dallagiacoma G, Alberti F et al. 2022. Prevention, diagnosis and treatment of cervical cancer: a systematic review of the impact of COVID-19 on patient care. Prev. Med. 164:107264
     [Google Scholar]
  32. 32.
    Rao SR, Kampan N, Chew KT et al. 2022. The impact of the COVID-19 pandemic on the national HPV immunization program in Malaysia. Front. Public Health 10:907720
     [Google Scholar]
  33. 33.
    Nogueira-Rodrigues A, Flores MG, Macedo Neto AO et al. 2022. HPV vaccination in Latin America: coverage status, implementation challenges and strategies to overcome it. Front. Oncol. 12:984449
     [Google Scholar]
  34. 34.
    Bénard É, Drolet M, Laprise JF et al. 2023. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis. Lancet Glob. Health 11:1e48–58
     [Google Scholar]
  35. 35.
    Bracke X, Roberts J, McVeigh TP. 2021. A systematic review and meta-analysis of telephone versus in-person genetic counseling in BRCA1/BRCA2 genetic testing. J. Genet. Couns. 30:2563–73
     [Google Scholar]
  36. 36.
    Bowen DJ, Rentscher KE, Wu A et al. 2021. Learning from and leveraging multi-level changes in responses to the COVID 19 pandemic to facilitate breast cancer prevention efforts. Int. J. Environ. Res. Public Health 18:136999
     [Google Scholar]
  37. 37.
    Norman ML, Malcolmson J, Randall Armel S et al. 2022. Stay at home: implementation and impact of virtualising cancer genetic services during COVID-19. J. Med. Genet. 59:123–27
     [Google Scholar]
  38. 38.
    Costanzo S, De Summa S, Maurmo L et al. 2023. Remote versus in-person BRCA1/2 non-carriers test disclosure: patients’ choice during COVID-19 pandemic restriction. Fam. Cancer 22:143–48
     [Google Scholar]
  39. 39.
    Mehraeen E, SeyedAlinaghi S, Heydari M et al. 2023. Telemedicine technologies and applications in the era of COVID-19 pandemic: a systematic review. Health Informatics J. 29:214604582231167431
     [Google Scholar]
  40. 40.
    Rubenstein RN, Stern CS, Plotsker EL et al. 2022. Effects of COVID-19 on mastectomy and breast reconstruction rates: a national surgical sample. J. Surg. Oncol. 126:2205–13
     [Google Scholar]
  41. 41.
    Borella F, Bertero L, Di Giovanni F et al. 2023. COVID-19 and breast cancer: analysis of surgical management of a large referral center during the 2020–2021 pandemic period. Curr. Oncol. 30:54767–78
     [Google Scholar]
  42. 42.
    O'Mara AE, Benedict C, Kurian AW et al. 2022. Risk-reducing salpingo-oophorectomy consults and practices during the COVID-19 pandemic. Gynecol. Oncol. Rep. 42:101036
     [Google Scholar]
  43. 43.
    COVIDSurg Collab 2020. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br. J. Surg. 107:1440–49
     [Google Scholar]
  44. 44.
    Manchanda R, Oxley S, Ghaem-Maghami S et al. 2021. COVID-19 and the impact on gynecologic cancer care. Int. J. Gynaecol. Obstet. 155:Suppl. 194–101
     [Google Scholar]
  45. 45.
    Oxley S, Kalra A, Sideris M et al. 2023. Impact of multiple COVID-19 waves on gynaecological cancer services in the UK. Cancers 15:41273
     [Google Scholar]
  46. 46.
    Figueroa JD, Gray E, Pashayan N et al. 2021. The impact of the COVID-19 pandemic on breast cancer early detection and screening. Prev. Med. 151:106585
     [Google Scholar]
  47. 47.
    Mayo M, Potugari B, Bzeih R et al. 2021. Cancer screening during the COVID-19 pandemic: a systematic review and meta-analysis. Mayo Clin. Proc. Innov. Qual. Outcomes 5:1109–17
     [Google Scholar]
  48. 48.
    Ng JS, Hamilton DG. 2022. Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: a rapid review and meta-analysis. J. Med. Screen. 29:209–18
     [Google Scholar]
  49. 49.
    Dennis LK, Hsu CH, Arrington AK. 2021. Reduction in standard cancer screening in 2020 throughout the US. Cancers 13:235918
     [Google Scholar]
  50. 50.
    Alagoz O, Lowry KP, Kurian AW et al. 2021. Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J. Natl. Cancer. Inst. 113:1484–94
     [Google Scholar]
  51. 51.
    Sprague BL, Lowry KP, Miglioretti DL et al. 2021. Changes in mammography utilization by women's characteristics during the first 5 months of the COVID-19 pandemic. J. Natl. Cancer. Inst. 113:1161–67
     [Google Scholar]
  52. 52.
    Screen. Immun. Team 2020. Breast screening programme: England, 2018–19 Natl. stat. rep., NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england---2018-19. Accessed July 11, 2023
  53. 53.
    Screen. Immun. Team 2021. Breast screening programme: England, 2019–20 Natl. stat. rep., NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england---2019-20. Accessed July 11, 2023
  54. 54.
    Screen. Immun. Team 2022. Breast screening programme: England, 2020–21 Natl. stat. rep., NHS Digital https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england---2020-21. Accessed July 11, 2023
  55. 55.
    Screen. Immun. Team 2023. Breast screening programme: England, 2021–22 Natl. stat. rep., NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england---2021-22. Accessed July 11, 2023
  56. 56.
    Hudson SM, Binysh K, Duffy SW. 2023. Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery?. J. Med. Screen. 30:287–91
     [Google Scholar]
  57. 57.
    Yacona K, Hanna MW, Niyazi S et al. 2022. Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?. J. Clin. Imaging Sci. 12:35
     [Google Scholar]
  58. 58.
    Kortlever TL, de Jonge L, Wisse PHA et al. 2021. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic. Prev. Med. 151:106643
     [Google Scholar]
  59. 59.
    Mazidimoradi A, Tiznobaik A, Salehiniya H. 2022. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J. Gastrointest. Cancer 53:3730–44
     [Google Scholar]
  60. 60.
    Chen RC, Haynes K, Du S et al. 2021. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol 7:6878–84
     [Google Scholar]
  61. 61.
    de Jonge L, Worthington J, van Wifferen F et al. 2021. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol. Hepatol. 6:4304–14
     [Google Scholar]
  62. 62.
    Mohl JT, Ciemins EL, Miller-Wilson LA et al. 2023. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017–2020. JAMA Netw. Open 6:1e2251384
     [Google Scholar]
  63. 63.
    Degeling K, Baxter N, Emery J et al. 2020. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic. medRxiv 20117630
  64. 64.
    Mandrik O, Chilcott J, Thomas C. 2022. Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: a decision analysis to prepare for future screening disruption. Prev. Med. 160:107076
     [Google Scholar]
  65. 65.
    Giorgi Rossi P, Carrozzi G, Falini P et al. 2023. The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys in 2020. eLife 12:e81804
     [Google Scholar]
  66. 66.
    Muschol J, Strauss C, Gissel C. 2022. COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis. J. Cancer Res. Clin. Oncol. https://doi.org/10.1007/s00432-022-04433-z
    [Google Scholar]
  67. 67.
    Bright D, Song J, Hillier S et al. 2022. Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study. Lancet 400:Suppl. 1S25
     [Google Scholar]
  68. 68.
    Walker MJ, Meggetto O, Gao J et al. 2021. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: a provincial, population-based study. Prev. Med. 151:106586
     [Google Scholar]
  69. 69.
    Castanon A, Rebolj M, Pesola F et al. 2022. COVID-19 disruption to cervical cancer screening in England. J. Med. Screen. 29:3203–8
     [Google Scholar]
  70. 70.
    Burger EA, Jansen EE, Killen J et al. 2021. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J. Med. Screen. 28:2213–16
     [Google Scholar]
  71. 71.
    Smith MA, Burger EA, Castanon A et al. 2021. Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: a modelled analysis. Prev. Med. 151:106623
     [Google Scholar]
  72. 72.
    Kontopantelis E, Mamas MA, Webb RT et al. 2022. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: a registry-based study. PLOS Med. 19:2e1003904
     [Google Scholar]
/content/journals/10.1146/annurev-med-051022-122257
Loading
Effects on Cancer Prevention from the COVID-19 Pandemic
Annual Review of Medicine 75, 1 (2024); https://doi.org/10.1146/annurev-med-051022-122257
/content/journals/10.1146/annurev-med-051022-122257
/content/journals/10.1146/annurev-med-051022-122257
Loading

Data & Media loading...

Supplemental Material

Supplementary Data

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error